Inclisiran sodium is a double-stranded small interfering RNA (siRNA) molecule that inhibits the transcription of PCSK9. Inclisiran sodium can be used for hyperlipidemia and cardiovascular disease (CVD) research[1].
Molecular Weight:
17284.72
Purity:
98.1
Formula:
C529H664F12N176Na43O316P43S6
Target:
PCSK9,Small Interfering RNA (siRNA)
Application Notes:
Oligonucleotides
* VAT and and shipping costs not included. Errors and price changes excepted